Facebook
Twitter
Telegram
Report an ErrorG1 Therapeutics Financial Statements 2011-2024 | GTHX
Annual Financial Statements G1 Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
173 M | 161 M | 423 M | 914 M | 787 M | 702 M | 466 M | - | - | - | - | - | - |
Shares |
51.7 M | 43.6 M | 41.9 M | 37.9 M | 37.5 M | 33.3 M | 18.2 M | - | - | - | - | - | - |
Historical Prices |
3.35 | 3.7 | 10.1 | 24.1 | 19.4 | 21.4 | 23.9 | - | - | - | - | - | - |
Net Income |
-48 M | -148 M | -148 M | -99.3 M | -122 M | -85.3 M | -60.1 M | -30.3 M | -20.3 M | - | - | - | - |
Revenue |
82.5 M | 51.3 M | 31.5 M | 45.3 M | - | - | - | - | 522 K | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-39.5 M | -136 M | -142 M | -96.5 M | -129 M | -89.3 M | -61 M | -30.4 M | -15.4 M | - | - | - | - |
Interest Expense |
-5.32 M | -9.68 M | -4.97 M | -1.37 M | 6.59 M | 4 M | 847 K | 100 K | -4.84 M | - | - | - | - |
EBITDA |
-39 M | -136 M | -142 M | -95.9 M | -129 M | -89.1 M | -60.9 M | -30.2 M | -15.4 M | - | - | - | - |
Operating Expenses |
122 M | 187 M | 174 M | 142 M | 129 M | 89.3 M | 61 M | - | - | - | - | - | - |
General and Administrative Expenses |
71.1 M | 100 M | 95.7 M | 68.5 M | 40 M | 18.6 M | 7.09 M | 5.23 M | 3.22 M | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement G1 Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
52.2 M | 51.9 M | 51.8 M | 51.7 M | 51.6 M | 51.5 M | 42.8 M | 42.7 M | 42.7 M | 42.6 M | 42.4 M | 42.1 M | 40.7 M | 38.1 M | 38 M | 37.8 M | 37.7 M | 37.6 M | 37.5 M | 37.5 M | 37.4 M | 37.2 M | 33.8 M | 32.8 M | 29.4 M | 28.4 M | 28.3 M | 14.2 M | 1.5 M | 1.49 M | 1.49 M | 1.49 M | 1.45 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-10.2 M | - | -18.2 M | 8.71 M | -27.6 M | - | -25.3 M | -39.4 M | -49.2 M | -40 M | -42.5 M | -39.4 M | -26.4 M | -25.3 M | -11.7 M | -31.2 M | -31 M | -35.4 M | -32.4 M | -30.7 M | -24 M | -24.1 M | -19.9 M | -20.9 M | -20.4 M | -17 M | -15.6 M | -15.2 M | -12.3 M | -10.4 M | -6.56 M | -7.38 M | -5.95 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
14.5 M | - | 12.3 M | 42.4 M | 12.9 M | - | 23.6 M | 10.6 M | 6.9 M | 5.8 M | 4.86 M | 6.6 M | 14.2 M | 16.5 M | 26.6 M | 2.14 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-9.05 M | - | -16.4 M | 11.5 M | -25.7 M | - | -21.5 M | -37 M | -46.8 M | -37.6 M | -41.1 M | -38.2 M | -25.5 M | -24.1 M | -9.74 M | -30.8 M | -31.8 M | -36.6 M | -34 M | -32.6 M | -25.9 M | -26.1 M | -20.8 M | -21.7 M | -20.7 M | -17.3 M | -15.9 M | -15.4 M | -12.4 M | -10.4 M | -6.61 M | -7.43 M | -5.95 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
-1.17 M | - | -931 K | -1.5 M | -1.85 M | - | -2.5 M | -2.48 M | -2.41 M | -2.19 M | -1 M | -1.01 M | -769 K | -780 K | -998 K | -388 K | 798 K | 1.11 M | 1.66 M | 1.89 M | 1.93 M | 1.99 M | 904 K | 785 K | 315 K | 301 K | 328 K | 185 K | 33 K | 2 K | 56 K | 50 K | -8 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-8.93 M | - | -16.2 M | 11.6 M | -25.6 M | - | -21.4 M | -36.8 M | -46.7 M | -37.6 M | -40.8 M | -38.1 M | -25.4 M | -23.9 M | -9.28 M | -30.5 M | -31.7 M | -36.6 M | -33.8 M | -32.5 M | -25.8 M | -26.1 M | -20.7 M | -21.6 M | -20.7 M | -17.3 M | -15.9 M | -15.3 M | -12.4 M | -10.4 M | -6.57 M | -7.4 M | -5.95 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
23.5 M | - | 28.7 M | 30.9 M | 38.7 M | - | 45.1 M | 47.5 M | 53.7 M | 43.4 M | 46 M | 44.8 M | 39.8 M | 40.6 M | 36.3 M | 33 M | 31.8 M | 36.6 M | 34 M | 32.6 M | 25.9 M | 26.1 M | 20.8 M | 21.7 M | 20.7 M | 17.3 M | 15.9 M | 15.4 M | 12.4 M | 10.4 M | 6.61 M | 7.43 M | 5.95 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
15.1 M | - | 16.8 M | 17.4 M | 21.8 M | - | 24.4 M | 25.7 M | 26.7 M | - | 24.3 M | 25.2 M | 23 M | - | 18.4 M | 14.4 M | 11.4 M | - | 11.1 M | 9.09 M | 7.8 M | - | 4.95 M | 3.27 M | 3.38 M | - | 1.88 M | 1.71 M | 1.29 M | - | 918 K | 975 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency